Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Jenburkt Pharmaceuticals Ltd.

Dec 12 BSE 1089.55 (+ 9.55 0.88%)

Volume412

Prev. Close
1080.00

Open Price
1086.60

Today's Low / High

1052.00 1098.60

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

936.70 1410.00

Jenburkt Pharmaceuticals Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	151.37	141.63	136.14	123.73	108.87
Other Operating Revenues	0.33	0.33	0.61	0.25	0.43
Total Operating Revenues	151.69	141.97	136.75	123.98	109.29

Other Income	6.72	4.67	5.12	4.95	4.31
Total Revenue	158.41	146.63	141.87	128.93	113.60

EXPENSES
Cost Of Materials Consumed	8.51	8.39	11.12	11.74	6.78
Purchase Of Stock-In Trade	21.26	22.41	20.55	21.98	20.13
Operating And Direct Expenses	1.16	0.73	0.80	0.63	0.34
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.12	-0.39	1.34	-2.28	3.18
Employee Benefit Expenses	45.54	42.49	38.81	36.49	32.38
Finance Costs	0.45	0.27	0.37	0.43	0.47
Depreciation And Amortisation Expenses	2.73	2.34	2.26	1.90	2.04
Other Expenses	34.95	35.22	33.77	28.17	26.63
Total Expenses	114.48	111.46	109.01	99.06	91.96

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	43.93	35.18	32.86	29.87	21.64

Profit/Loss Before Tax	43.93	35.18	32.86	29.87	21.64

Tax Expenses-Continued Operations
Current Tax	11.90	9.64	8.56	7.35	5.45
Deferred Tax	-0.21	-0.52	-0.23	0.30	-0.39
Tax For Earlier Years	0.18	0.08	-0.08	-0.07	0.09
Total Tax Expenses	11.87	9.20	8.26	7.57	5.14
Profit/Loss After Tax And Before ExtraOrdinary Items	32.06	25.98	24.61	22.30	16.50

Profit/Loss From Continuing Operations	32.06	25.98	24.61	22.30	16.50

Profit/Loss For The Period	32.06	25.98	24.61	22.30	16.50

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	72.65	58.86	53.90	48.58	35.96
Diluted EPS (Rs.)	72.65	58.86	53.90	48.58	35.96

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	6.75	6.36	5.51	4.68	0.00
Equity Dividend Rate (%)	180.00	153.00	144.00	120.00	102.00

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	151.37
Other Operating Revenues	0.33
Total Operating Revenues	151.69
Other Income	6.72
Total Revenue	158.41
EXPENSES
Cost Of Materials Consumed	8.51
Purchase Of Stock-In Trade	21.26
Operating And Direct Expenses	1.16
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.12
Employee Benefit Expenses	45.54
Finance Costs	0.45
Depreciation And Amortisation Expenses	2.73
Other Expenses	34.95
Total Expenses	114.48
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	43.93
Profit/Loss Before Tax	43.93
Tax Expenses-Continued Operations
Current Tax	11.90
Deferred Tax	-0.21
Tax For Earlier Years	0.18
Total Tax Expenses	11.87
Profit/Loss After Tax And Before ExtraOrdinary Items	32.06
Profit/Loss From Continuing Operations	32.06
Profit/Loss For The Period	32.06
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	72.65
Diluted EPS (Rs.)	72.65
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	6.75
Equity Dividend Rate (%)	180.00